Items per page
Sort by

Send to:

Choose Destination

Results: 10

Cited In for PubMed (Select 1681751)


Cognitive impairment in patients with AIDS - prevalence and severity.

Watkins CC, Treisman GJ.

HIV AIDS (Auckl). 2015 Jan 29;7:35-47. doi: 10.2147/HIV.S39665. eCollection 2015. Review.


HIV-1 proteins, Tat and gp120, target the developing dopamine system.

Fitting S, Booze RM, Mactutus CF.

Curr HIV Res. 2015;13(1):21-42.


Neuropsychiatric complications of aging with HIV.

Watkins CC, Treisman GJ.

J Neurovirol. 2012 Aug;18(4):277-90. doi: 10.1007/s13365-012-0108-z. Epub 2012 May 30. Review.


When human immunodeficiency virus meets chemokines and microglia: neuroprotection or neurodegeneration?

Mocchetti I, Campbell LA, Harry GJ, Avdoshina V.

J Neuroimmune Pharmacol. 2013 Mar;8(1):118-31. doi: 10.1007/s11481-012-9353-4. Epub 2012 Apr 15. Review.


Prefrontal dopaminergic and enkephalinergic synaptic accommodation in HIV-associated neurocognitive disorders and encephalitis.

Gelman BB, Lisinicchia JG, Chen T, Johnson KM, Jennings K, Freeman DH Jr, Soukup VM.

J Neuroimmune Pharmacol. 2012 Sep;7(3):686-700. doi: 10.1007/s11481-012-9345-4. Epub 2012 Mar 6.


Hyperdopaminergic tone in HIV-1 protein treated rats and cocaine sensitization.

Ferris MJ, Frederick-Duus D, Fadel J, Mactutus CF, Booze RM.

J Neurochem. 2010 Nov;115(4):885-96. doi: 10.1111/j.1471-4159.2010.06968.x. Epub 2010 Oct 5.


The human immunodeficiency virus-1-associated protein, Tat1-86, impairs dopamine transporters and interacts with cocaine to reduce nerve terminal function: a no-net-flux microdialysis study.

Ferris MJ, Frederick-Duus D, Fadel J, Mactutus CF, Booze RM.

Neuroscience. 2009 Apr 10;159(4):1292-9. doi: 10.1016/j.neuroscience.2009.01.024. Epub 2009 Jan 20.


Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse.

Chang L, Wang GJ, Volkow ND, Ernst T, Telang F, Logan J, Fowler JS.

Neuroimage. 2008 Aug 15;42(2):869-78. doi: 10.1016/j.neuroimage.2008.05.011. Epub 2008 May 20.


Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS.

Ferris MJ, Mactutus CF, Booze RM.

Neurosci Biobehav Rev. 2008 Jul;32(5):883-909. doi: 10.1016/j.neubiorev.2008.01.004. Epub 2008 Mar 18. Review.


Human immunodeficiency virus type 1 infection of the brain.

Atwood WJ, Berger JR, Kaderman R, Tornatore CS, Major EO.

Clin Microbiol Rev. 1993 Oct;6(4):339-66. Review.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk